New Data from SkylineDx Demonstrates Merlin CP-GEP Test’s Superior Melanoma Risk Stratification
— New data analysis clarifies misleading benchmarks released by a competitor; separate SkylineDx analysis demonstrates Merlin CP-GEP Test provides stronger metastatic-risk stratification and superior predictive accuracy for SLNB outcomes compared to 31-GEP/i31-SLNB, when evaluated under harmonized and scientifically rigorous conditions — Recent publication in early-stage melanoma shows Merlin CP-GEP Test correctly identifies High-Risk patients with […]